This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kandel, E. S.
Right arrow Articles by Hay, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kandel, E. S.
Right arrow Articles by Hay, N.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2002, p. 7831-7841, Vol. 22, No. 22
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.22.7831-7841.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage

Eugene S. Kandel,1,{dagger} Jennifer Skeen,1 Nathan Majewski,1 Antonio Di Cristofano,2,{ddagger} Pier Paolo Pandolfi,2 Claudine S. Feliciano,1 Andrei Gartel,1 and Nissim Hay1*

Department of Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60607,1 Department of Human Genetics and Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, New York2

Received 30 April 2002/ Returned for modification 17 June 2002/ Accepted 20 August 2002

Activation of Akt, or protein kinase B, is frequently observed in human cancers. Here we report that Akt activation via overexpression of a constitutively active form or via the loss of PTEN can overcome a G2/M cell cycle checkpoint that is induced by DNA damage. Activated Akt also alleviates the reduction in CDC2 activity and mitotic index upon exposure to DNA damage. In addition, we found that PTEN null embryonic stem (ES) cells transit faster from the G2/M to the G1 phase of the cell cycle when compared to wild-type ES cells and that inhibition of phosphoinositol-3-kinase (PI3K) in HEK293 cells elicits G2 arrest that is alleviated by activated Akt. Furthermore, the transition from the G2/M to the G1 phase of the cell cycle in Akt1 null mouse embryo fibroblasts (MEFs) is attenuated when compared to that of wild-type MEFs. These results indicate that the PI3K/PTEN/Akt pathway plays a role in the regulation of G2/M transition. Thus, cells expressing activated Akt continue to divide, without being eliminated by apoptosis, in the presence of continuous exposure to mutagen and accumulate mutations, as measured by inactivation of an exogenously expressed herpes simplex virus thymidine kinase (HSV-tk) gene. This phenotype is independent of p53 status and cannot be reproduced by overexpression of Bcl-2 or Myc and Bcl-2 but seems to counteract a cell cycle checkpoint mediated by DNA mismatch repair (MMR). Accordingly, restoration of the G2/M cell cycle checkpoint and apoptosis in MMR-deficient cells, through reintroduction of the missing component of MMR, is alleviated by activated Akt. We suggest that this new activity of Akt in conjunction with its antiapoptotic activity may contribute to genetic instability and could explain its frequent activation in human cancers.

* Corresponding author. Mailing address: Department of Molecular Genetics, M/C 669, University of Illinois at Chicago, 900 South Ashland Ave., Chicago, IL 60607. Phone: (312) 355-1684. Fax: (312) 355-2032. E-mail: nhay{at}uic.edu.

{dagger} Present address: The Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH 44195.

{ddagger} Present address: Fox Chase Cancer Center, Philadelphia, PA 19111.

Molecular and Cellular Biology, November 2002, p. 7831-7841, Vol. 22, No. 22
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.22.7831-7841.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vitolo, M. I., Weiss, M. B., Szmacinski, M., Tahir, K., Waldman, T., Park, B. H., Martin, S. S., Weber, D. J., Bachman, K. E. (2009). Deletion of PTEN Promotes Tumorigenic Signaling, Resistance to Anoikis, and Altered Response to Chemotherapeutic Agents in Human Mammary Epithelial Cells. Cancer Res. 69: 8275-8283 [Abstract] [Full Text]  
  • Kalous, J., Kubelka, M., Solc, P., Susor, A., Motlik, J. (2009). AKT (protein kinase B) is implicated in meiotic maturation of porcine oocytes. Reproduction 138: 645-654 [Abstract] [Full Text]  
  • Lei, H., Quelle, F. W. (2009). FOXO Transcription Factors Enforce Cell Cycle Checkpoints and Promote Survival of Hematopoietic Cells after DNA Damage. Mol Cancer Res 7: 1294-1303 [Abstract] [Full Text]  
  • An, J., Zhang, C., Polavarapu, R., Zhang, X., Zhang, X., Yepes, M. (2008). Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112: 2787-2794 [Abstract] [Full Text]  
  • Qiao, J., Kang, J., Ishola, T. A., Rychahou, P. G., Evers, B. M., Chung, D. H. (2008). Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc. Natl. Acad. Sci. USA 105: 12891-12896 [Abstract] [Full Text]  
  • Segrelles, C., Lu, J., Hammann, B., Santos, M., Moral, M., Cascallana, J. L., Lara, M. F., Rho, O., Carbajal, S., Traag, J., Beltran, L., Martinez-Cruz, A. B., Garcia-Escudero, R., Lorz, C., Ruiz, S., Bravo, A., Paramio, J. M., DiGiovanni, J. (2007). Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis. Cancer Res. 67: 10879-10888 [Abstract] [Full Text]  
  • Ferry, D. R., Anderson, M., Beddard, K., Tomlinson, S., Atherfold, P., Obszynska, J., Harrison, R., Jankowski, J. (2007). A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical Response. Clin. Cancer Res. 13: 5869-5875 [Abstract] [Full Text]  
  • Feng, C., Yu, A., Liu, Y., Zhang, J., Zong, Z., Su, W., Zhang, Z., Yu, D., Sun, Q.-Y., Yu, B. (2007). Involvement of Protein Kinase B/AKT in Early Development of Mouse Fertilized Eggs. Biol. Reprod. 77: 560-568 [Abstract] [Full Text]  
  • Cristiano, B. E., Chan, J. C., Hannan, K. M., Lundie, N. A., Marmy-Conus, N. J., Campbell, I. G., Phillips, W. A., Robbie, M., Hannan, R. D., Pearson, R. B. (2006). A Specific Role for AKT3 in the Genesis of Ovarian Cancer through Modulation of G2-M Phase Transition. Cancer Res. 66: 11718-11725 [Abstract] [Full Text]  
  • Pankow, S., Bamberger, C., Klippel, A., Werner, S. (2006). Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase. J. Cell Sci. 119: 4033-4046 [Abstract] [Full Text]  
  • Nyakern, M., Cappellini, A., Mantovani, I., Martelli, A. M. (2006). Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways.. Molecular Cancer Therapeutics 5: 1559-1570 [Abstract] [Full Text]  
  • Li, Y., Rogulski, K., Zhou, Q., Sims, P. J., Prochownik, E. V. (2006). The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase I.. Mol. Cell. Biol. 26: 3401-3413 [Abstract] [Full Text]  
  • O'Brien, V., Brown, R. (2006). Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27: 682-692 [Abstract] [Full Text]  
  • Knauf, J. A., Ouyang, B., Knudsen, E. S., Fukasawa, K., Babcock, G., Fagin, J. A. (2006). Oncogenic RAS Induces Accelerated Transition through G2/M and Promotes Defects in the G2 DNA Damage and Mitotic Spindle Checkpoints. J. Biol. Chem. 281: 3800-3809 [Abstract] [Full Text]  
  • Poh, T. W., Pervaiz, S. (2005). LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway. Cancer Res. 65: 6264-6274 [Abstract] [Full Text]  
  • Katayama, K., Fujita, N., Tsuruo, T. (2005). Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M Transition. Mol. Cell. Biol. 25: 5725-5737 [Abstract] [Full Text]  
  • Hirose, Y., Katayama, M., Mirzoeva, O. K., Berger, M. S., Pieper, R. O. (2005). Akt Activation Suppresses Chk2-Mediated, Methylating Agent-Induced G2 Arrest and Protects from Temozolomide-Induced Mitotic Catastrophe and Cellular Senescence. Cancer Res. 65: 4861-4869 [Abstract] [Full Text]  
  • Viniegra, J. G., Martinez, N., Modirassari, P., Losa, J. H., Cobo, C. P., Lobo, V. J. S.-A., Luquero, C. I. A., Alvarez-Vallina, L., Ramon y Cajal, S., Rojas, J. M., Sanchez-Prieto, R. (2005). Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATM. J. Biol. Chem. 280: 4029-4036 [Abstract] [Full Text]  
  • Le, X.-F., Lammayot, A., Gold, D., Lu, Y., Mao, W., Chang, T., Patel, A., Mills, G. B., Bast, R. C. Jr. (2005). Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling. J. Biol. Chem. 280: 2092-2104 [Abstract] [Full Text]  
  • Lee, C., Kim, J.-S., Waldman, T. (2004). PTEN Gene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer Cells. Cancer Res. 64: 6906-6914 [Abstract] [Full Text]  
  • Feng, J., Tamaskovic, R., Yang, Z., Brazil, D. P., Merlo, A., Hess, D., Hemmings, B. A. (2004). Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation. J. Biol. Chem. 279: 35510-35517 [Abstract] [Full Text]  
  • Yuan, J.-H., Feng, Y., Fisher, R. H., Maloid, S., Longo, D. L., Ferris, D. K. (2004). Polo-Like Kinase 1 Inactivation Following Mitotic DNA Damaging Treatments Is Independent of Ataxia Telangiectasia Mutated Kinase. Mol Cancer Res 2: 417-426 [Abstract] [Full Text]  
  • Tanno, S., Yanagawa, N., Habiro, A., Koizumi, K., Nakano, Y., Osanai, M., Mizukami, Y., Okumura, T., Testa, J. R., Kohgo, Y. (2004). Serine/Threonine Kinase AKT Is Frequently Activated in Human Bile Duct Cancer and Is Associated with Increased Radioresistance. Cancer Res. 64: 3486-3490 [Abstract] [Full Text]  
  • Lancet, J. E., Karp, J. E. (2003). Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapy. Blood 102: 3880-3889 [Abstract] [Full Text]  
  • Hirose, Y., Katayama, M., Stokoe, D., Haas-Kogan, D. A., Berger, M. S., Pieper, R. O. (2003). The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents. Mol. Cell. Biol. 23: 8306-8315 [Abstract] [Full Text]  
  • Shtivelman, E. (2003). Promotion of Mitosis by Activated Protein Kinase B After DNA Damage Involves Polo-Like Kinase 1 and Checkpoint Protein CHFR. Mol Cancer Res 1: 959-969 [Abstract] [Full Text]  
  • Liao, Y., Hung, M.-C. (2003). Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis. Mol. Cell. Biol. 23: 6836-6848 [Abstract] [Full Text]  
  • Chandrasekher, G., Sailaja, D. (2003). Differential Activation of Phosphatidylinositol 3-Kinase Signaling during Proliferation and Differentiation of Lens Epithelial Cells. IOVS 44: 4400-4411 [Abstract] [Full Text]  
  • Peng, X.-d., Xu, P.-Z., Chen, M.-L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G., Hay, N. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17: 1352-1365 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»